Claudia S. Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudia S. Rodrigues has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ines Pankonien
BioISI-Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Campo Grande, C8 bdg, Lisboa, 1749-016, Portugal
4 shared publications - Margarida Duarte Amaral
BioISI—Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Campo Grande, C8 bdg, 1749-016 Lisboa, Portugal
4 shared publications - Violeta Railean
BioISI - Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Campo Grande C8 bdg, 1749-016, Lisboa, Portugal
2 shared publications Adelina Amorim
Pulmonology Department of ULS São João, Cystic Fibrosis Reference Center, ULS São João, Rua de Miguel Bombarda 234, 4050-377, Porto, Portugal; Faculty of Medicine, University of Porto (FMUP), Rua de Miguel Bombarda 234, 4050-377, Porto, Portugal
1 shared publicationAires Duarte
BioISI–Biosystems and Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Lisboa, Portugal
1 shared publication- Ana Luisa Pereira
Pharmaceutical Service, ULS São João, Rua de Miguel Bombarda 234, 4050-377, Porto, Portugal
1 shared publication
Latest Publications
- 15 July 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 246, 108238
N1303K (p.Asn1303Lys) variant: Expanding frontiers in the treatment of cystic fibrosis
- 15 July 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 246, 108238
N1303K (p.Asn1303Lys) variant: Expanding frontiers in the treatment of cystic fibrosis
- Open Access
- 6 February 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (3) , 542-547
Personalized therapy with CFTR modulators: Response of p.Ile148Asn variant
- 6 February 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (3) , 542-547
Open AccessPersonalized therapy with CFTR modulators: Response of p.Ile148Asn variant
- Open Access
- 2 May 2022
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 5 (9) , e202101326
Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial–mesenchymal transition
Mutations in the CFTR anion channel cause cystic fibrosis (CF) and have also been related to higher cancer incidence. Previously we proposed that this is linked to an emerging role of functional CFTR in protecting against epithelial–mesenchymal transition (EMT). However, the pathways bridging dysfunctional CFTR to EMT remain elusive. Here, we applied systems biology to address this question. Our data show that YAP1 is aberrantly active in the presence of mutant CFTR, interacting with F508del, but not with wt-CFTR, and that YAP1 knockdown rescues F508del-CFTR processing and function. Subsequent analysis of YAP1 interactors and roles in cells expressing either wt- or F508del-CFTR reveal that YAP1 is an important mediator of the fibrotic/EMT processes in CF. Alongside, five main pathways emerge here as key in linking mutant CFTR to EMT, namely, (1) the Hippo pathway; (2) the Wnt pathway; (3) the TGFβ pathway; (4) the p53 pathway; and (5) MYC signaling. Several potential hub proteins which mediate the crosstalk among these pathways were also identified, appearing as potential therapeutic targets for both CF and cancer.
- 2 May 2022
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 5 (9) , e202101326
Open AccessExploring YAP1-centered networks linking dysfunctional CFTR to epithelial–mesenchymal transition
Mutations in the CFTR anion channel cause cystic fibrosis (CF) and have also been related to higher cancer incidence. Previously we proposed that this is linked to an emerging role of functional CFTR in protecting against epithelial–mesenchymal transition (EMT). However, the pathways bridging dysfunctional CFTR to EMT remain elusive. Here, we applied systems biology to address this question. Our data show that YAP1 is aberrantly active in the presence of mutant CFTR, interacting with F508del, but not with wt-CFTR, and that YAP1 knockdown rescues F508del-CFTR processing and function. Subsequent analysis of YAP1 interactors and roles in cells expressing either wt- or F508del-CFTR reveal that YAP1 is an important mediator of the fibrotic/EMT processes in CF. Alongside, five main pathways emerge here as key in linking mutant CFTR to EMT, namely, (1) the Hippo pathway; (2) the Wnt pathway; (3) the TGFβ pathway; (4) the p53 pathway; and (5) MYC signaling. Several potential hub proteins which mediate the crosstalk among these pathways were also identified, appearing as potential therapeutic targets for both CF and cancer.
- Open Access
- 28 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2688
CFTR, Cell Junctions and the Cytoskeleton
The multi-organ disease cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein, a cAMP regulated chloride (Cl−) and bicarbonate (HCO3−) ion channel expressed at the apical plasma membrane (PM) of epithelial cells. Reduced CFTR protein results in decreased Cl− secretion and excessive sodium reabsorption in epithelial cells, which consequently leads to epithelial dehydration and the accumulation of thick mucus within the affected organs, such as the lungs, pancreas, gastrointestinal (GI) tract, reproductive system and sweat glands. However, CFTR has been implicated in other functions besides transporting ions across epithelia. The rising number of references concerning its association to actin cytoskeleton organization, epithelial cell junctions and extracellular matrix (ECM) proteins suggests a role in the formation and maintenance of epithelial apical basolateral polarity. This review will focus on recent literature (the last 10 years) substantiating the role of CFTR in cell junction formation and actin cytoskeleton organization with its connection to the ECM.
- 28 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2688
Open AccessCFTR, Cell Junctions and the Cytoskeleton
The multi-organ disease cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein, a cAMP regulated chloride (Cl−) and bicarbonate (HCO3−) ion channel expressed at the apical plasma membrane (PM) of epithelial cells. Reduced CFTR protein results in decreased Cl− secretion and excessive sodium reabsorption in epithelial cells, which consequently leads to epithelial dehydration and the accumulation of thick mucus within the affected organs, such as the lungs, pancreas, gastrointestinal (GI) tract, reproductive system and sweat glands. However, CFTR has been implicated in other functions besides transporting ions across epithelia. The rising number of references concerning its association to actin cytoskeleton organization, epithelial cell junctions and extracellular matrix (ECM) proteins suggests a role in the formation and maintenance of epithelial apical basolateral polarity. This review will focus on recent literature (the last 10 years) substantiating the role of CFTR in cell junction formation and actin cytoskeleton organization with its connection to the ECM.